Sunday, August 16, 2020

Research Post - DIAMAG (ALAMAG-03) Device for Treatment of Neurodegenerative Diseases



  •  Stimulates production of melatonin which is a natural stress protector; provides sedation, sleeping recovery, anxiety level reduction
  • Reduces blood pressure, increases blood oxygen saturation; activates metabolic processes
  • Relieves pain attacks without painkillers usage
  • Normalizes muscle tone, restores motor function, giving back the patient the ability to carry on activities of daily living
  • Restores mind lucidity, normalizes hearing and vision
  • Improves coordination and memory, thinking processes
  • Improves visual acuity, normalizes light sensitivity, increases the field of view limits, improving trophic in the retina and optic nerve

 INDICATIONS FOR USE

  • Osteochondrosis of the cervical spine with symptoms of cranialgia, cephalgia
  • Sleep disturbances
  • Effects of cerebrovascular accident
  • Parkinson’s disease
  • Chronic cerebral ischemia
  • Transient ischemic attack
  • Chronic iridocyclitis
  • Migraine neuralgia, migraine

Four operation modes

  • Program No. 1 -treatment of brain conditions (consequences of a cerebrovascular accident, transient ischemic attack, chronic cerebral ischemia, migraine)
  • Program No. 2 - treatment of osteochondrosis of the cervical spine with cephalgia and cranialgia
  • Program No.3 - treatment of eye diseases (chronic iridocyclitis).
  • Program No. 4 to treat Parkinson's disease.

 

Tech Specs

Generates pulsed magnetic fields

a) field types:

- “travelling” - serial actuation of all emitters of flexible emitting lines from the 1st emitter to the 6th in cycles (programs No.1, No.2, No.3);

- “static” simultaneous actuation of all the emitters (program No.4).

b) pulse frequency within each packet:

- 30 pulses/sec (program No.3);

- 7 pulses/sec (programs No.1, No.4);

Relative deviation of the frequency value is within 5%;

c) peak values of the magnetic field density on the emitters’ surface:

- 10 mT (programs No.1, No.2, No.3);

- 8 mT (program No.4);

Absolute deviation of the field density peak value (B) is within [0.2B+0.6] mT.

This post is not advertising - for information purposes only

 

No comments:

Post a Comment

Research Post - Application of PEMF Technology for Treatment of Neurodegenerative Disorders (Part II)

  Before we go on with our story, I would like to pinpoint some more in formation about the affect of PEMF treatments on brain:   FlexPuls...